preview

Carvedilol Phosphate Case Study

Better Essays

6. Results and Discussion:
6.1 Preformulation Studies:
6.1.1 Selection of drug:
Carvedilol Phosphate is a non-selective β-adrenergic blocking agent with α-1 blocking activity. It is widely used in clinical practice for the treatment of cardio vascular diseases like hypertension, congestive heart failure, myocardial infarction, etc. Treatment with the β-adrenoceptor blocking agents, metoprolol and carvedilol, has been shown to improve symptoms and left ventricular ejection fraction and to reduce mortality in patients with heart failure. However, a recent clinical study showed that carvedilol had a more favourable effect on the survival rate of patients with heart failure in comparison with metoprolol. Carvedilol is used as a racemic mixture clinically. S-carvedilol has …show more content…

Mean values (n=3) of drug dissolution profiles are as shown in table 36. Standard deviation was not more than 2 in any case. It was observed that after storage of three months in stability chamber, drug release was decreased approximately by 5% while lag time was unaffected. Also for pellets stored at ambient conditions lag time was unaffected and drug release was lowered approximately by 5%.
Final formulation (T1) contains formulations C2 and C7, 209 and 211 mg respectively and each contains 20 mg of the drug. Formulation T1 is used for in vivo

Get Access